685 related articles for article (PubMed ID: 31241117)
1. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
2. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
3. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
4. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
[TBL] [Abstract][Full Text] [Related]
5. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
6. Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative Activity.
Kuhn PS; Cremer L; Gavriluta A; Jovanović KK; Filipović L; Hummer AA; Büchel GE; Dojčinović BP; Meier SM; Rompel A; Radulović S; Tommasino JB; Luneau D; Arion VB
Chemistry; 2015 Sep; 21(39):13703-13. PubMed ID: 26260662
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties.
Fandzloch M; Dobrzańska L; Jędrzejewski T; Jezierska J; Wiśniewska J; Łakomska I
J Biol Inorg Chem; 2020 Feb; 25(1):109-124. PubMed ID: 31741123
[TBL] [Abstract][Full Text] [Related]
9. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
[TBL] [Abstract][Full Text] [Related]
10. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
[TBL] [Abstract][Full Text] [Related]
12. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells.
Correa RS; Bomfim LM; Oliveira KM; Moreira DRM; Soares MBP; Ellena J; Bezerra DP; Batista AA
J Inorg Biochem; 2019 Sep; 198():110751. PubMed ID: 31220757
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure and biological evaluation of bis salicylaldehyde-4(N)-ethylthiosemicarbazone ruthenium(iii) triphenylphosphine.
Prabhakaran R; Kalaivani P; Jayakumar R; Zeller M; Hunter AD; Renukadevi SV; Ramachandran E; Natarajan K
Metallomics; 2011 Jan; 3(1):42-8. PubMed ID: 21132183
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
[TBL] [Abstract][Full Text] [Related]
17. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
18. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium complexes in different oxidation states: synthesis, crystal structure, spectra and redox properties.
Jabłońska-Wawrzycka A; Rogala P; Michałkiewicz S; Hodorowicz M; Barszcz B
Dalton Trans; 2013 May; 42(17):6092-101. PubMed ID: 23381742
[TBL] [Abstract][Full Text] [Related]
20. Antiparasitic activities of novel ruthenium/lapachol complexes.
Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
